Biography Technologies, UCSD Moores Cancer Center to buy concrete 4 technology to learn about CLL
LifeTechnologies Corporation (NASDAQ: FRESHNESS and the University of California at San Diego Moores Cancer Center today announced a partnership to application SOLiD™ 4 genomic assay technology in a study program to weigh long-lived lymphocytic leukemia (CLL), a cancer of the ashen blood cells. The CLL study is made tenable away funding from the Citizen Institutes of Fitness and choose okay scientists to scan the fit transcriptomes of 96 CLL tumor samples in favour of potency biomarkers.
“Life Technologies is proud to be working in conjunction with UCSD Moores Cancer Center, and supporting their biomarker inspection of hematological malignancies CLL”
CLL is entire of four pipeline types of leukemia, which at the start affects adults averaging 70 years disused, and causes a boeotian spread in the total of corpse-like blood cells called B cells in the bone marrow. The cancerous cells spread from the marrow to the blood, and can also touch the lymph nodes and other organs, such as the liver and spleen. CLL finally causes the bone marrow to prove inadequate and weakens the untouched way.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
